Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jurriaan R G Jansen

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Cell Reports|February 3, 2021
Predicting protein condensate formation using machine learningGuido van Mierlo, Jurriaan R G Jansen, Jie Wang, et al.
Expert Opinion on Drug Safety|January 23, 2023
First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanerceptKimberly Velthuis, Naomi T Jessurun, Thi D M Nguyen, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Cell Reports|February 3, 2021
Predicting protein condensate formation using machine learningGuido van Mierlo, Jurriaan R G Jansen, Jie Wang, et al.
Expert Opinion on Drug Safety|January 23, 2023
First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanerceptKimberly Velthuis, Naomi T Jessurun, Thi D M Nguyen, et al.
Pageof 1